← FDA Drug Approvals (Drugs@FDA)

ADHANSIA XR

NDA · New Drug Application · Sponsor: PURDUE PHARMA LP · Approved 2019-02-27

Drug application

FDA Application #

NDA212038

Application type

New Drug Application

Brand name

ADHANSIA XR

Generic name

Methylphenidate Hydrochloride

Active ingredients

METHYLPHENIDATE HYDROCHLORIDE

Dosage form

CAPSULE, EXTENDED RELEASE

Route

ORAL

Marketing status

Discontinued

Sponsor

PURDUE PHARMA LP

First approval

2019-02-27

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown